Farag M. Mosallam

1.4k total citations
29 papers, 1.1k citations indexed

About

Farag M. Mosallam is a scholar working on Materials Chemistry, Molecular Biology and Biomedical Engineering. According to data from OpenAlex, Farag M. Mosallam has authored 29 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Materials Chemistry, 7 papers in Molecular Biology and 7 papers in Biomedical Engineering. Recurrent topics in Farag M. Mosallam's work include Nanoparticles: synthesis and applications (14 papers), Bacterial biofilms and quorum sensing (5 papers) and Advanced Nanomaterials in Catalysis (4 papers). Farag M. Mosallam is often cited by papers focused on Nanoparticles: synthesis and applications (14 papers), Bacterial biofilms and quorum sensing (5 papers) and Advanced Nanomaterials in Catalysis (4 papers). Farag M. Mosallam collaborates with scholars based in Egypt, Saudi Arabia and India. Farag M. Mosallam's co-authors include Ahmed I. El‐Batal, Gharieb S. El‐Sayyad, Rasha Mohammad Fathy, Mohamed Gobara, M. Abd Elkodous, Ibrahim Y. Abdelrahman, Hebatallah A. Nasser, Nawal E. Al‐Hazmi, Ahmad Baraka and Mahmoud M. Bendary and has published in prestigious journals such as International Journal of Biological Macromolecules, Toxicology and Applied Pharmacology and Colloids and Surfaces B Biointerfaces.

In The Last Decade

Farag M. Mosallam

28 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Farag M. Mosallam Egypt 15 654 302 135 126 124 29 1.1k
Nafeesa Khatoon India 15 427 0.7× 249 0.8× 137 1.0× 163 1.3× 178 1.4× 23 917
Mani Divya India 20 488 0.7× 200 0.7× 205 1.5× 118 0.9× 84 0.7× 50 1.1k
Mohsen Zargar Iran 18 703 1.1× 298 1.0× 162 1.2× 105 0.8× 47 0.4× 53 1.2k
Hidayat Mohd Yusof Malaysia 10 621 0.9× 253 0.8× 129 1.0× 79 0.6× 64 0.5× 12 914
Hossein Vahidi Iran 21 873 1.3× 493 1.6× 199 1.5× 153 1.2× 157 1.3× 49 1.5k
Rohini Kitture India 18 891 1.4× 417 1.4× 139 1.0× 141 1.1× 38 0.3× 25 1.4k
Sadegh Khorrami Iran 12 533 0.8× 283 0.9× 123 0.9× 102 0.8× 78 0.6× 13 861
Anastasia Semenova Russia 14 644 1.0× 371 1.2× 88 0.7× 237 1.9× 38 0.3× 81 1.3k
Andrey B. Lisitsyn Russia 13 604 0.9× 373 1.2× 86 0.6× 231 1.8× 38 0.3× 61 1.3k
Viorica Railean‐Plugaru Poland 22 853 1.3× 518 1.7× 256 1.9× 174 1.4× 96 0.8× 56 1.7k

Countries citing papers authored by Farag M. Mosallam

Since Specialization
Citations

This map shows the geographic impact of Farag M. Mosallam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Farag M. Mosallam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Farag M. Mosallam more than expected).

Fields of papers citing papers by Farag M. Mosallam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Farag M. Mosallam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Farag M. Mosallam. The network helps show where Farag M. Mosallam may publish in the future.

Co-authorship network of co-authors of Farag M. Mosallam

This figure shows the co-authorship network connecting the top 25 collaborators of Farag M. Mosallam. A scholar is included among the top collaborators of Farag M. Mosallam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Farag M. Mosallam. Farag M. Mosallam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Karam, Heba M., et al.. (2024). A new approach of nano-metformin as a protector against radiation-induced cardiac fibrosis and inflammation via CXCL1/TGF-Β pathway. Naunyn-Schmiedeberg s Archives of Pharmacology. 397(9). 6919–6927. 1 indexed citations
3.
Mosallam, Farag M., et al.. (2024). Silver secnidazole nano‐hybrid emulsion‐based probiotics as a novel antifungal formula against multidrug‐resistant vaginal pathogens. Biotechnology and Applied Biochemistry. 72(2). 295–310. 2 indexed citations
4.
Mosallam, Farag M., et al.. (2024). Impeding microbial biofilm formation and Pseudomonas aeruginosa virulence genes using biologically synthesized silver Carthamus nanoparticles. Microbial Cell Factories. 23(1). 240–240. 5 indexed citations
5.
Bendary, Mahmoud M., Farag M. Mosallam, Rasha Mosbah, et al.. (2024). Boosting the Anti‐ Helicobacter Efficacy of Azithromycin through Natural Compounds: Insights From In Vitro, In Vivo, Histopathological, and Molecular Docking Investigations. Helicobacter. 29(4). e13110–e13110. 2 indexed citations
6.
Mosallam, Farag M., et al.. (2024). Eradication of Klebsiella pneumoniae pulmonary infection by silver oxytetracycline nano-structure. AMB Express. 14(1). 62–62. 2 indexed citations
7.
Mosallam, Farag M., Eman A. Helmy, Hebatallah A. Nasser, & Ahmed I. El‐Batal. (2024). Novel griseofulvin zinc nanohybrid emulsion for intensifying the antimicrobial control of dermatophytes and some opportunistic pathogens. Journal de Mycologie Médicale. 34(3). 101489–101489. 4 indexed citations
9.
Mosallam, Farag M., et al.. (2023). Curcumin clarithromycin nano-form a promising agent to fight Helicobacter pylori infections. World Journal of Microbiology and Biotechnology. 39(12). 324–324. 13 indexed citations
10.
Mosallam, Farag M., et al.. (2023). Alleviating the virulence of Pseudomonas aeruginosa and Staphylococcus aureus by ascorbic acid nanoemulsion. Research in Microbiology. 174(7). 104084–104084. 8 indexed citations
11.
Abbas, Hisham A., et al.. (2022). Novel silver metformin nano-structure to impede virulence of Staphylococcus aureus. AMB Express. 12(1). 84–84. 12 indexed citations
12.
Mosallam, Farag M., et al.. (2022). Knocking down Pseudomonas aeruginosa virulence by oral hypoglycemic metformin nano emulsion. World Journal of Microbiology and Biotechnology. 38(7). 119–119. 10 indexed citations
13.
Mosallam, Farag M., Eman A. Helmy, Mahmoud M. Bendary, & Ahmed I. El‐Batal. (2021). Potency of a novel synthesized Ag-eugenol nanoemulsion for treating some bacterial and fungal pathogens. Journal of materials research/Pratt's guide to venture capital sources. 36(7). 1524–1537. 28 indexed citations
14.
15.
Elkodous, M. Abd, Gharieb S. El‐Sayyad, Hebatallah A. Nasser, et al.. (2019). Engineered Nanomaterials as Potential Candidates for HIV Treatment: Between Opportunities and Challenges. Journal of Cluster Science. 30(3). 531–540. 32 indexed citations
16.
Elkodous, M. Abd, Gharieb S. El‐Sayyad, M. I. A. Abdel Maksoud, et al.. (2019). Fabrication of Ultra-Pure Anisotropic Zinc Oxide Nanoparticles via Simple and Cost-Effective Route: Implications for UTI and EAC Medications. Biological Trace Element Research. 196(1). 297–317. 58 indexed citations
17.
El‐Batal, Ahmed I., Hebatallah A. Nasser, & Farag M. Mosallam. (2019). Fabrication and characterization of cobalt hyaluronic acid nanostructure via gamma irradiation for improving biomedical applications. International Journal of Biological Macromolecules. 147. 1328–1342. 18 indexed citations
19.
Elkodous, M. Abd, Gharieb S. El‐Sayyad, Ibrahim Y. Abdelrahman, et al.. (2019). Therapeutic and diagnostic potential of nanomaterials for enhanced biomedical applications. Colloids and Surfaces B Biointerfaces. 180. 411–428. 154 indexed citations
20.
El‐Batal, Ahmed I., Gharieb S. El‐Sayyad, Farag M. Mosallam, & Rasha Mohammad Fathy. (2019). Penicillium chrysogenum-Mediated Mycogenic Synthesis of Copper Oxide Nanoparticles Using Gamma Rays for In Vitro Antimicrobial Activity Against Some Plant Pathogens. Journal of Cluster Science. 31(1). 79–90. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026